Omega Fund V, L.P. is > 10% Shareholder of Kronos Bio, Inc.. Currently has a direct ownership of 3.82 Million shares of KRON, which is worth approximately $4.39 Million. The most recent transaction as insider was on Oct 14, 2020, when has been sold 450,000 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $8,550,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.82M
0% 3M change
0% 12M change
Total Value Held $4.39 Million

Omega Fund V, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2020
BUY
Open market or private purchase
$8,550,000 $19.0 p/Share
450,000 Added 10.54%
3,818,283 Common Stock
Oct 14 2020
BUY
Conversion of derivative security
$54,083,636 $16.15 p/Share
3,348,832 Added 49.86%
3,368,283 Common Stock

Also insider at

MORF
Morphic Holding, Inc. Healthcare
NUVB
Nuvation Bio Inc. Healthcare
OFV

Omega Fund V, L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on KRON

Follow Kronos Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRON shares.

Notify only if

Insider Trading

Get notified when an Kronos Bio, Inc. insider buys or sells KRON shares.

Notify only if

News

Receive news related to Kronos Bio, Inc.

Track Activities on KRON